Literature DB >> 9869583

Increase in quinolone resistance in a Haemophilus influenzae strain isolated from a patient with recurrent respiratory infections treated with ofloxacin.

J Vila1, J Ruiz, F Sanchez, F Navarro, B Mirelis, M T de Anta, G Prats.   

Abstract

The increase in the level of quinolone resistance of Haemophilus influenzae clinical isolates during ofloxacin therapy of a patient with recurrent respiratory infections was investigated. The first isolate (MIC of ciprofloxacin of 2 microg/ml) and the second isolate (MIC of 32 microg/ml) belonged to the same clone, as shown by pulsed-field gel electrophoresis, and the increase in the resistance level was associated with a substitution in Ser-84 to Arg in the ParC protein. These results emphasize the potential risk of development of quinolone-resistant H. influenzae during fluoroquinolone therapy in patients with recurrent respiratory infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9869583      PMCID: PMC89038     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from The Netherlands.

Authors:  H J Bootsma; A Troelstra; A van Veen-Rutgers; F R Mooi; A J de Neeling; B P Overbeek
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

2.  Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence.

Authors:  K Groeneveld; L van Alphen; P P Eijk; G Visschers; H M Jansen; H C Zanen
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

3.  Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency.

Authors:  S Chamberland; F Malouin; H R Rabin; T Schollaardt; T R Parr; L E Bryan
Journal:  J Antimicrob Chemother       Date:  1990-06       Impact factor: 5.790

4.  In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Authors:  A B Brueggemann; K C Kugler; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Detection of quinolone resistance in Haemophilus spp.

Authors:  J E Corkill; A Percival; P McDonald; A I Bamber
Journal:  J Antimicrob Chemother       Date:  1994-11       Impact factor: 5.790

6.  Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC.

Authors:  M Georgiou; R Muñoz; F Román; R Cantón; R Gómez-Lus; J Campos; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

7.  Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis.

Authors:  J Campos; F Román; M Georgiou; C García; R Gómez-Lus; R Cantón; H Escobar; F Baquero
Journal:  J Infect Dis       Date:  1996-12       Impact factor: 5.226

8.  Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.

Authors:  J Vila; J Ruiz; P Goñi; M T De Anta
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease.

Authors:  S L Barriere; J A Hindler
Journal:  Ann Pharmacother       Date:  1993-03       Impact factor: 3.154

10.  Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.

Authors:  J Vila; J Ruiz; F Marco; A Barcelo; P Goñi; E Giralt; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

  10 in total
  15 in total

1.  Quinolone resistance-determining regions of gyrA and parC in Pasteurella multocida strains with different levels of nalidixic acid resistance.

Authors:  M Cárdenas; J Barbé; M Llagostera; E Miró; F Navarro; B Mirelis; G Prats; I Badiola
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  The next generation: fluoroquinolones in the management of acute lower respiratory infection in adults.

Authors:  P J Moss; R G Finch
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

3.  Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin.

Authors:  Xinying Li; Noriel Mariano; James J Rahal; Carl M Urban; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Melting curve analysis for rapid detection of topoisomerase gene mutations in Haemophilus influenzae.

Authors:  Shigeki Nakamura; Katsunori Yanagihara; Yoshitomo Morinaga; Koichi Izumikawa; Masafumi Seki; Hiroshi Kakeya; Yoshihiro Yamamoto; Shimeru Kamihira; Shigeru Kohno
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

5.  Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.

Authors:  T A Davies; L M Kelly; D B Hoellman; L M Ednie; C L Clark; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.

Authors:  Carmen Puig; José Manuel Tirado-Vélez; Laura Calatayud; Fe Tubau; Junkal Garmendia; Carmen Ardanuy; Sara Marti; Adela G de la Campa; Josefina Liñares
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

Review 7.  Transferable Mechanisms of Quinolone Resistance from 1998 Onward.

Authors:  Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

8.  Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV.

Authors:  Xinying Li; Noriel Mariano; James J Rahal; Carl M Urban; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.

Authors:  María Pérez-Vázquez; Federico Román; Belén Aracil; Rafael Cantón; José Campos
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

10.  Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients.

Authors:  Yingzhi Liu; Lowell Ling; Sunny H Wong; Maggie Ht Wang; J Ross Fitzgerald; Xuan Zou; Shisong Fang; Xiaodong Liu; Xiansong Wang; Wei Hu; Hung Chan; Yan Wang; Dan Huang; Qing Li; Wai T Wong; Gordon Choi; Huachun Zou; David Sc Hui; Jun Yu; Gary Tse; Tony Gin; William Kk Wu; Matthew Tv Chan; Lin Zhang
Journal:  EClinicalMedicine       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.